Received May 4, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 2 | 946065 | LA |
Patient received HEPLISAV-B as second dose (after receiving Twinrix). Patient had requested Twinrix specifically. Patient did not report any side effects or adverse events.
None